The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer's Disease Population

Overview

Journal Neuropsychiatr Dis Treat

Publisher Dove Medical Press

Specialty Psychiatry

Date 2020 Apr 11

PMID 32273709

Citations 2

Authors

Qianqian Shi

Faying Zhou

Jing Mei

Haimei Yang

Huiyun Li

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the effect of Type 2 diabetes mellitus (T2DM) on the development of neuropsychiatric symptoms (NPS) in early Alzheimer's disease (AD).

Methods: From September 2017 to March 2019, a cross-sectional study was conducted on the clinical data of 158 early AD patients over 65 years old in the Department of Neurology of Daping Hospital. All early stage of AD patients were divided into early stage of AD with NPS group and early stage of AD without NPS group according to the presence or absence of NPS. Clinical data of age, sex, body mass index (BMI), smoking and alcohol consumption, history of hypertension, hyperlipidemia, white matter leisure (WML) and T2DM, MMSE, CDR and NPI-Q scores were collected. Multivariate logistic regression analyses were performed to examine the relationship between T2DM and NPS in early AD.

Results: Compared with the early stage of AD group without NPS, the early stage of AD group with NPS was older, the proportion of women was higher, the proportion of T2DM, hypertension, hyperlipidemia and WML was higher, and the MMSE score was lower (P< 0.05). T2DM was an independent risk factor for NPS in early stage of AD patients (OR 3.48, 95% CI 2.91-3.84). The incidence of T2DM in AD patients with depression, anxiety, nighttime behavioral disturbances, and appetite disturbances was significantly higher than in AD patients without these symptoms. T2DM was an independent risk factor of depression (OR 2.04, 95% CI 1.71-2.38), anxiety (OR 1.69, 95% CI 1.38-1.97), nighttime behavioral disturbances (OR 1.95, 95% CI 1.75-2.13) and appetite disturbances (OR 1.62, 95% CI 1.33-1.94) in early AD patients.

Conclusion: T2DM was an important independent risk factor for NPS in early AD, which promotes the occurrence of depression, anxiety, nighttime behavioral disturbances and appetite disturbances in early AD.

Citing Articles

Blood-based biomarkers in mild behavioral impairment: an updated overview.

Angelopoulou E, Androni X, Villa C, Hatzimanolis A, Scarmeas N, Papageorgiou S Front Neurol. 2025; 16:1534193.

PMID: 39980634 PMC: 11839432. DOI: 10.3389/fneur.2025.1534193.

Metabolic Profile of Alzheimer's Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?.

Gong Y, Luo H, Li Z, Feng Y, Liu Z, Chang J Metabolites. 2023; 13(8).

PMID: 37623897 PMC: 10456792. DOI: 10.3390/metabo13080954.

Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer's Disease.

Patil G, Kulsange S, Kazi R, Chirmade T, Kale V, Mote C ACS Pharmacol Transl Sci. 2023; 6(1):65-75.

PMID: 36654748 PMC: 9841776. DOI: 10.1021/acsptsci.2c00143.

References

Roh E, Song D, Kim M . Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med. 2016; 48:e216. PMC: 4892882. DOI: 10.1038/emm.2016.4. View

Leal S, Noche J, Murray E, Yassa M . Disruption of amygdala-entorhinal-hippocampal network in late-life depression. Hippocampus. 2017; 27(4):464-476. PMC: 5858586. DOI: 10.1002/hipo.22705. View

Gonzalez J, Peyrot M, McCarl L, Collins E, Serpa L, Mimiaga M . Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008; 31(12):2398-403. PMC: 2584202. DOI: 10.2337/dc08-1341. View

Leboucher A, Laurent C, Fernandez-Gomez F, Burnouf S, Troquier L, Eddarkaoui S . Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes. 2012; 62(5):1681-8. PMC: 3636620. DOI: 10.2337/db12-0866. View

Loonen A, Ivanova S . Circuits regulating pleasure and happiness in major depression. Med Hypotheses. 2016; 87:14-21. DOI: 10.1016/j.mehy.2015.12.013. View

Miller Y, Ma B, Tsai C, Nussinov R . Hollow core of Alzheimer's Abeta42 amyloid observed by cryoEM is relevant at physiological pH. Proc Natl Acad Sci U S A. 2010; 107(32):14128-33. PMC: 2922530. DOI: 10.1073/pnas.1004704107. View

Eustace A, Coen R, Walsh C, Cunningham C, Walsh J, Coakley D . A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease. Int J Geriatr Psychiatry. 2002; 17(10):968-73. DOI: 10.1002/gps.736. View

Cheng D, Noble J, Tang M, Schupf N, Mayeux R, Luchsinger J . Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord. 2011; 31(6):424-30. PMC: 3142096. DOI: 10.1159/000324134. View

Trento M, Trevisan M, Raballo M, Passera P, Charrier L, Cavallo F . Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest. 2014; 37(1):79-85. DOI: 10.1007/s40618-013-0028-7. View

10.

Morris J . The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43(11):2412-4. DOI: 10.1212/wnl.43.11.2412-a. View

11.

McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

12.

Roberts R, Knopman D, Przybelski S, Mielke M, Kantarci K, Preboske G . Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 2014; 82(13):1132-41. PMC: 3966799. DOI: 10.1212/WNL.0000000000000269. View

13.

Roy T, Lloyd C . Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012; 142 Suppl:S8-21. DOI: 10.1016/S0165-0327(12)70004-6. View

14.

Willette A, Johnson S, Birdsill A, Sager M, Christian B, Baker L . Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement. 2014; 11(5):504-510.e1. PMC: 4297592. DOI: 10.1016/j.jalz.2014.03.011. View

15.

Naicker K, Overland S, Johnson J, Manuel D, Skogen J, Sivertsen B . Symptoms of anxiety and depression in type 2 diabetes: Associations with clinical diabetes measures and self-management outcomes in the Norwegian HUNT study. Psychoneuroendocrinology. 2017; 84:116-123. DOI: 10.1016/j.psyneuen.2017.07.002. View

16.

Picinato M, Piltcher Haber E, Cipolla-Neto J, Curi R, Carvalho C, Carpinelli A . Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res. 2002; 33(3):156-60. DOI: 10.1034/j.1600-079x.2002.02903.x. View

17.

Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456-77. PMC: 3170532. DOI: 10.1093/brain/awr179. View

18.

Ulrich-Lai Y, Herman J . Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009; 10(6):397-409. PMC: 4240627. DOI: 10.1038/nrn2647. View

19.

Raudino F . Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review. Neurol Sci. 2013; 34(8):1275-82. DOI: 10.1007/s10072-013-1424-7. View

20.

Moulton C, Pickup J, Ismail K . The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015; 3(6):461-471. DOI: 10.1016/S2213-8587(15)00134-5. View